HIPERFERRITINEMIA IN MDS PATIENTS- POLISH RETROSPECTIVE MDS REGISTRY Results

被引：0

作者：

Dwilewicz-Trojaczek, J. ^{[1
]}

Madry, K. ^{[1
]}

Waszczuk-Gajda, A. ^{[1
]}

Stella-Holowiecka, B. ^{[2
]}

Mital, A. ^{[3
]}

Drozd-Sokolowska, J. ^{[1
]}

Wiater, E. ^{[1
]}

Kolkowska-Lesniak, A. ^{[4
]}

Szmigielska, A. ^{[5
]}

Mendrek, W. ^{[2
]}

Subocz, E. ^{[6
]}

Obara, A. ^{[7
]}

Biedron, M. ^{[8
]}

Zalewska, M. ^{[9
]}

Jachalska, A. ^{[10
]}

Kruger, W. ^{[11
]}

Katinas, K. ^{[11
]}

Guzicka-Kazimierczak, R. ^{[12
]}

Wasilewska, E. ^{[13
]}

Pedziwiatr, M. ^{[14
]}

Nowicki, A. ^{[15
]}

Kopacz, A. ^{[16
]}

Nowak, E. ^{[17
]}

Blasiak, A. ^{[18
]}

Wojciechowska, M. ^{[19
]}

Soroka-Wojtaszko, M. ^{[20
]}

Sedzimirska, M. ^{[21
]}

Gornik, S. ^{[22
]}

机构：

[1] Med Univ Warsaw, Warsaw, Poland

[2] Silesian Med Univ, Katowice, Poland

[3] Med Univ Gdansk, Gdansk, Poland

[4] Inst Hematol & Transfusiol, Warsaw, Poland

[5] Med Univ Lodz, Lodz, Poland

[6] Mil Inst Hlth Serv, Warsaw, Poland

[7] Holycross Canc Ctr, Kielce, Poland

[8] Med Univ Wroclaw, Wroclaw, Poland

[9] Specialist Hosp Torun, Torun, Poland

[10] Specialist Hosp Bydgoszcz, Bydgoszcz, Poland

[11] Dept Hematol & Internal Dis Poznan, Poznan, Poland

[12] Med Univ Szczecin, Szczecin, Poland

[13] Med Univ Bialystok, Bialystok, Poland

[14] Specialist Hosp Krakow, Krakow, Poland

[15] Med Univ Poznan, Poznan, Poland

[16] Specialist Hosp Rzeszow, Rzeszow, Poland

[17] Specialist Hosp Gorzow Wlkp, Gorzow Wielkopolski, Poland

[18] MSWiA Hosp, Warsaw, Poland

[19] Specialist Hosp Olsztyn, Olsztyn, Poland

[20] Med Univ Lublin, Lublin, Poland

[21] Lower Silesian Ctr Cellular Transplantat Wroclaw, Wroclaw, Poland

[22] Dept Internal Dis Zamosc, Zamosc, Poland

来源：

HAEMATOLOGICA | 2012年 / 97卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1453

引用

页码：579 / 579

页数：1

共 50 条

[1] HIPERFERRITINEMIA IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS - RETROSPECTIVE STUDY FROM A SINGLE CENTRE EXPERIENCE
Ionita, M.
Ionita, I.
Cheveresan, L.
Todorescu, V.
Ionita, C.
Calamar, D.
Oros, D.
Ionita, H.
HAEMATOLOGICA, 2015, 100 : 723 - 724
[2] AZACYTIDINE THERAPY FOR MDS PATIENTS: RETROSPECTIVE MULTICENTRE REGIONAL EXPERIENCE IN PATIENTS REPORTED IN THE LIGURIAN MDS REGISTRY
Minetto, P.
Mitscheunig, L.
Clavio, M.
Guolo, F.
De Astis, E.
Avenoso, D.
Bergamaschi, M.
Giannoni, L.
Del Corso, L.
Balleari, E.
Arboscello, E.
Pastori, G.
Calzamiglia, T.
Cavaliere, M.
Marani, C.
Goretti, R.
Racchi, O.
Cruciani, F.
Lovera, D.
Beltrami, G.
Ballerini, F.
Miglino, M.
Lemoli, R. M.
Ghio, R.
Gobbi, M.
HAEMATOLOGICA, 2014, 99 : 621 - 621
[3] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) in outpatient clinics - results of the outpatient MDS registry
Schmitz, S.
Boettger, I
Welslau, M.
Lerchenmueller, C.
Sauer, A.
Germing, U.
ONKOLOGIE, 2011, 34 : 289 - 289
[4] Treatment Patterns and Overall Survival in Patients with Intermediate-Risk MDS: A Retrospective Analysis in the Spanish MDS Registry
Diez-Campelo, Maria
Benlloch, Luis E.
Sasse, Emma
Wormser, David
Donoso, Leyla Hernandez
Colicino, Silvia
Bernal, Teresa
Molero Yordi, Antonieta
Tormo, Mar
Arnan Sangerman, Montserrat
Sanz, Guillermo
Diaz-Beya, Marina
Cedena Romero, Maria Teresa
Jerez, Andres
Merchan, Brayan
Valcarcel, David
BLOOD, 2021, 138
[5] HYPERFERRITINEMIA IS ASSOCIATED WITH IMPAIRED SURVIVAL IN PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROMES RESULTS FROM THE FIRST POLISH MDS REGISTRY
Waszczuk-Gajda, A.
Dwilewicz-Trojaczek, J.
Madry, K.
Drozd-Sokolowska, J.
Stella-Holowiecka, B.
Machowicz, R.
Mital, A.
Obara, A.
Szmigielska-Kaplon, A.
Sikorska, A.
Kolkowska-Lesniak, A.
Subocz, E.
Mendrek, W.
Szczepanska, M.
Biedron, M.
Jachalska, A.
Wasilewska, E.
Wojciechowska, M.
Guzicka-Kazmierczak, R.
Wiater, E.
Kopacz, A.
Katinas, K.
Kruger, W.
Dawidowska, A.
Zawirska, D.
Salamanczuk, Z.
Swiderska, A.
Gornik, S.
Sedzimirska, M.
Soroka-Wojtaszko, M.
Nowicki, A.
Jedrzejczak, W. W.
HAEMATOLOGICA, 2015, 100 : 722 - 722
[6] Diagnostic procedures and treatment of patients with myelodysplastic syndromes (MDS) in outpatient clinics. Results of the outpatient MDS registry
Schmitz, S.
Boettger, I.
Schnell, R.
Sauer, A.
Linde, H.
Severin, K.
Germing, U.
Steinmetz, T.
LEUKEMIA RESEARCH, 2013, 37 : S115 - S115
[7] Frailty is an independent prognostic marker for overall survival in MDS: Results of a Canadian MDS registry
Buckstein, R.
Prica, A.
Chodirker, L.
Zhu, N.
Nevill, T.
Leitch, H.
Yee, K.
Leber, B. F.
Sabloff, M.
Kumar, R.
Geddes, M.
Lenis, M.
Li, C.
Mamedov, A.
Khalaf, D.
Zhang, L.
Rockwood, K.
Alibhai, S.
Wells, R.
LEUKEMIA RESEARCH, 2013, 37 : S76 - S76
[8] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) - update of the outpatient MDS registry
Schmitz, S.
Boettger, I
Sauer, A.
Buschmann, D.
Germing, U.
Severin, K.
Steinmetz, H. T.
ONKOLOGIE, 2013, 36 : 242 - 242
[9] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) of low and intermediate-1 risk. Results of the outpatient MDS registry
Schmitz, S.
Boettger, I
Schnell, R.
Lerchenmueller, C.
Sauer, A.
Severin, K.
Germing, U.
Steinmetz, H. T.
ONKOLOGIE, 2012, 35 : 148 - 148
[10] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
Steinmetz, H. T.
Boettger, I
Lathan, B.
Sauer, A.
Severin, K.
Germing, U.
Schmitz, S.
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234

← 1 2 3 4 5 →